ArticleBritish journal of clinical pharmacology2025

Artificial intelligence modelling of tyrosine kinase inhibitors at risk of malabsorption and bioavailability-enhancing strategies.

Daan W Huntjens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.